Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

When we stratified the cumulative incidence curves by initial niraparib dose, we found that a lower initial dose appeared to be related to lower hematological toxicities numerically but this did not reach statistical significance ( p -value = 0.09 for thrombocytopenia, 0.05 for neutropenia, and 0.11 for anemia; Supplementary Materials, Figure S5 and Table S7 ). 4.

also in 111,027 other papers